Atrial Fibrillation
Conditions
Keywords
Integrated chronic care program, specialized outpatient AF clinic, Atrial Fibrillation guideline
Brief summary
Rationale: The treatment of patients with atrial fibrillation is often inadequate due to poor guideline adherence. An integrated chronic care program (ICCP) at a specialized AF-clinic was found to be superior to usual care provided by a cardiologist in terms of cardiovascular hospitalizations and cardiovascular mortality. Hypothesis: treatment at a specialized AF clinic is superior to usual care in terms of cardiovascular mortality and cardiovascular hospitalizations, cost-effectiveness, quality of life and guideline adherence. Objectives: primary objective is to show that an ICCP reduces cardiovascular hospitalizations and mortality. Study design: randomized controlled trial with two study arms: usual care provided by cardiologists (control) versus integrated chronic care program at a specialized AF clinic (intervention) in 8 hospitals in the Netherlands. The RACE4 is an event driven study. A total number of 246 events is needed. In total 1716 patients with newly diagnosed AF will be included. Total duration of the study is 5 years and 10 months with a minimal follow up of 1 year. Data is collected at inclusion, after 3, 6, 12 months, every year thereafter and at the end of the study. Study population: Patients older than 18 year with newly diagnosed AF. Intervention: The intervention is delivered through the specialized outpatient AF clinic. The multidisciplinary team at the AF clinic consists of a nurse practitioner or physician assistant or specialised cardiovascular nurse, cardiologist, and is guided by guidelines-based decision support software program based on the applicable ESC guideline recommendations. The use of a web-based patient centered management of patient's own medication (Medication manager TM) was optional. A standardized diagnostic, treatment and follow-up pathway was performed within the ICCP.
Interventions
OTHERSpecialized outpatient AF Clinic
OTHERUsual Care
Sponsors
Stichting Achmea Gezondheidszor
DSW
CZ Fonds
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Pfizer
Daiichi Sankyo
Maastricht University Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Patients with newly diagnosed AF detected on electrocardiogram (ECG), holter recordings or event recorder with a duration \> 30 seconds, 3 months before inclusion or 2. Patients with a history of diagnosed AF, with no regular control at a cardiologist for AF in the last 2 years and referred by a (non-)cardiologic medical specialist for new diagnostics or therapeutic issue; 3. Age ≥18 years.
Exclusion criteria
1. No electrocardiographic objectified AF; 2. Unstable heart failure defined as NYHA IV or heart failure necessitating hospital admission \< 3 months before inclusion; 3. Acute coronary syndrome (acute myocardial infarction or instable angina pectoris, with two of the following characteristics: chest pain and/ or ischemic electrocardiographic changes, and/ or cardiac enzyme rise) \< 3 months before inclusion; 4. Untreated hyperthyroidism or \< 3 months euthyroidism before inclusion; 5. Foreseen pacemaker, internal cardioverter defibrillator, and/ or cardiac resynchronization therapy; 6. Cardiac surgery ≤ 3 months before inclusion; 7. Planned cardiac surgery; 8. Regular control and treatment, also for AF, at another specialized outpatient cardiac clinic; 9. Patient is not able to fill in the questionnaires; 10. Participation in other clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is a composite of unplanned admission to the hospital for any cardiovascular reason and cardiovascular death. | Follow up with minimum of 1 year and a maximum of 5 years and 10 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total number of unplanned cardiovascular hospitalizations | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | — |
| All components of the primary endpoint | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | — |
| All-cause mortality | Minimum of 1 year and a maximum of 5 years and 10 months | — |
| Total number of unplanned all-cause hospitalizations | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | — |
| Duration of unplanned cardiovascular hospitalizations | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | — |
| Total number of unplanned hospitalizations related to atrial fibrillation | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | — |
| Duration of unplanned hospitalizations related to atrial fibrillation | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | — |
| Duration of unplanned all-cause hospitalizations | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | — |
| Costs and cost-effectiveness | baseline, 1 year, 2 years, 3 years | Costs, Quality Adjusted Life Years (QALYs) and Cost-effectiveness (Incremental Cost-Effectiveness Ratio - ICER) |
| Implementation of care | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | The extent to which the comprehensive cardiovascular treatment is in accordance with the most recent ESC guidelines Management of Atrial Fibrillation, the HF guidelines of acute and chronic heart failure and the CVD prevention guidelines |
| Patient Quality of life | Baseline, 1 year, 2 years, 3 years | General health-related QoL is measured by using the SF-36 |
| Anxiety and/ or depression | Baseline, 1 year, 2 years, 3 years | HADS-NL |
| Knowledge of AF | Baseline, 1 year, 2 years, 3 years | Netherlands Knowledge Scale on AF |
| Compliance to medication | Baseline, 1 year, 2 years, 3 years | MMAS |
| Recurrent unplanned cardiovascular hospitalizations | Follow up with minimum of 1 year and a maximum of 5 years and 10 months | — |
Countries
Netherlands
Outcome results
None listed